Pharma

- Advertisement -
Ad imageAd image
Hitachi and Shionogi deploy genAI in drug regulatory work

Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…

PADCEV + KEYTRUDA improve Survival in Bladder Cancer

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…

Nxera Launches Pipeline for Obesity, Weight Management

Nxera Pharma has launched a wide range of unique treatments. These aim…

Lantern Pharma completes LP-300 Lung cancer trial signup

Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies…

Protagenic Gets Japan Patent for Stilbenoid Drug Program

Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent…

Infocom Launches DigiPro AI Compliance Tool for Pharma

Infocom Corporation has launched the DigiPro® AI Compliance Check Service , which…

MediciNova Shares Update on ALS, Triglyceride Trials

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and…

Curadh, Alpha Fusion Advance Astatine-211 Collaboration

Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase their…

COSMOS taps RELEX to optimize supply chain and growth

COSMOS Pharmaceutical Corporation, one of Japan’s largest drugstore chains, has chosen RELEX…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community